- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06955000
Efficacy of Interval Aerobic Training Versus Laser Puncture Therapy on Restless Leg Syndrome in Copd Patient
Efficacy of Interval Aerobic Training Versus Laser Puncture Therapy on the Severity of Restless Leg Syndrome in Chronic Obstructive Lung Disease Patients
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Alexandria, Egypt
- Ola Mohamed Elsayed Elgohary
-
Contact:
- ola elgohary, lecturer
- Phone Number: 01227191398
- Email: ola.elgohary@pua.edu.eg
-
Contact:
- ola elgohary, lecturer
- Phone Number: 0122719398
- Email: ola.elgohary@pua.edu.eg
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Men with COPD who were between the ages of 40 and 60 and had a BMI between 25.5 and 29.0 were eligible to enroll if they had received a diagnosis of COPD at least two years priorAn intense desire to move the legs is frequently accompanied by unpleasant and uncomfortable leg sensations. Patients usually experience worsening symptoms when they are at rest, sitting, or lying down. Walking and stretching are examples of physical activity that can help reduce these symptoms to some or all of their intensity
Exclusion Criteria:
- 1) Individuals suffering from acute infections and malignant diseases; 2) Individuals with a history of kidney disease, hiatus hernia, severe gastro-esophageal reflux, and osteoporosis 3) Patients with severe anemia and congestive heart failure 4) Individuals with severe neurological and musculoskeletal conditions.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: aerobic training
3 sessions per week,40 mints each session, mild to moderate intensity exercise
|
Patients in this group were instructed to sit on a stationary bicycle ergometer.
The patients will be given explained the aerobic interval exercise training program and the intensity will be assessed using a modified Borg scale
|
|
Experimental: laser puncture therapy
There were three sessions per week, each lasting 40 minutes.
Five minutes later, a laser probe was applied to the acupuncture sites on the leg.
|
This group's patients were all exposed to LLLT utilising Phyaction CL Phyaction, Bilzen, Belgium, which had the following specs: frequency 500 Hz, output 5-20 MW, wavelength 905 nm.
For five minutes, a laser probe was applied to acupuncture sites
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Restless Legs Syndrome Rating Scale (IRLS):
Time Frame: 3 month
|
Developed as a tool for assessing the severity Restless Legs Syndrome (RLS), the 10-item questionnaire asks respondents to use Likert-type ratings to indicate how acutely the disorder has affected them over the course of the past week.
Questions can be divided into one of two catego- ries: disorder symptoms (nature, intensity, and frequency) and their impact (sleep issues, distur- bances in daily functioning, and resultant changes in mood)
|
3 month
|
|
Fatigue severity scale (FSS):
Time Frame: 3 month
|
The FSS is a short questionnaire that requires you to rate your level of fatigue.
The FSS questionnaire contains nine statements that rate the severity of your fatigue symptoms.
Read each statement and circle a number from 1 to 7, based on how accurately it reflects your condition during the past week and the extent to which you agree or disagree that the statement applies to you
|
3 month
|
|
Six mint walk test:
Time Frame: 3 month
|
the 6-minute walk test (6MWT) is a key study providing a functional, therapeutic response, and prognostic data that is valuable in the care of patients with respiratory as well as cardiac diseases.
It is used widely due to its simplicity and reproducibility,
|
3 month
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Hemoglobin Test:
Time Frame: 3 month
|
Red blood cells contain hemoglobin, a protein that is rich in iron.
It transports oxygen throughout the body from the lungs.
|
3 month
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Aberrant Motor Behavior in Dementia
- Neurologic Manifestations
- Nervous System Diseases
- Mental Disorders
- Pathologic Processes
- Chronic Disease
- Disease Attributes
- Behavioral Symptoms
- Respiratory Tract Diseases
- Neurobehavioral Manifestations
- Lung Diseases
- Sleep Wake Disorders
- Sleep Disorders, Intrinsic
- Dyssomnias
- Dyskinesias
- Psychomotor Disorders
- Parasomnias
- Lung Diseases, Obstructive
- Pulmonary Disease, Chronic Obstructive
- Psychomotor Agitation
- Restless Legs Syndrome
Other Study ID Numbers
- restless leg syndrome and copd
Plan for Individual participant data (IPD)
Study Data/Documents
-
Study Protocol
Information comments:
Döner A, Taşci S, Bilgin A. The Effect of Massage, Acupressure and Reflexology on Restless Legs Syndrome Severity and Sleep Quality in Patients Receiving Haemodialysis Treatment: A Systematic Review and Meta-Analysis. Nursing Open. 2025 Feb;12(2):e70135.
26-Mitchell UH, Johnson AW, Myrer B. Comparison of two infrared devices in their effectiveness in reducing symptoms associated with RLS. Physiotherapy theory and practice. 2011 Jun 1;27(5):352-9.
27-Tang L, Zhao N, Gao X, Li J, Yu X, Liang R, Xie C, Li L, Wang Q, Yang W. Acupuncture treatment of restless legs syndrome: a randomized clinical controlled study protocol based on PET-CT and fMRI. Frontiers in Psychiatry. 2024 Dec 24; 15:1481167.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chronic Obstructive Pulmonary Disease
-
Spire, Inc.ResMedCompletedSevere Chronic Obstructive Pulmonary Disease | Moderate Chronic Obstructive Pulmonary DiseaseUnited States
-
Karaganda Medical UniversityCompletedChronic Obstructive Pulmonary Disease | Chronic Obstructive Pulmonary Disease Moderate | Chronic Obstructive Pulmonary Disease SevereKazakhstan
-
Randall DebattistaUniversity of Malta, Faculty of Health SciencesNot yet recruitingChronic Obstructive Pulmonary Disease Moderate | Acute Exacerbation of COPD | Chronic Obstructive Pulmonary Disease Severe
-
University of LeicesterUniversity Hospitals, Leicester; University of StrathclydeRecruitingChronic Obstructive Pulmonary Disease (COPD) | Chronic Obstructive Lung Disease | Chronic Obstructive Airway DiseaseUnited Kingdom
-
National Taipei University of Nursing and Health...TerminatedChronic Pulmonary Disease | Chronic Obstructive Pulmonary Disease Exacerbation | Chronic Obstructive Pulmonary Disease With ExacerbationTaiwan
-
Cukurova UniversityCompletedAnesthesia | Chronic Obstructive Pulmonary Disease Moderate | Lungcancer | Chronic Obstructive Pulmonary Disease Severe | Chronic Obstructive Pulmonary Disease MildTurkey
-
Mylan Inc.Theravance BiopharmaCompletedChronic Obstructive Pulmonary Disease (COPD)United States
-
University Hospital, GhentGlaxoSmithKline; University GhentCompletedChronic Obstructive Pulmonary Disease (COPD)Belgium
-
Optimum Patient CareRespiratory Effectiveness Group; Boehringer Ingelheim Pharmaceutical Company... and other collaboratorsUnknownChronic Obstructive Pulmonary Disease (13645005)United States
-
Poitiers University HospitalCompletedBroncho Chronic Obstructive Pulmonary DiseaseFrance